Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer that affects white blood cells. Survival rates tend to ... Experts don’t exactly know what causes CLL. However, there are risk factors ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left without hope.” ...

Using human T cells and leukemia cells in specialized mouse models ... offering a groundbreaking innovation that could eventually improve survival and quality of life for patients with some ...

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...

The lab integrates molecular and cell biology, transcriptomics, metabolomics, and in vivo modeling to uncover the factors that promote leukemia survival, migration, and treatment resistance. Key ...